AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits
Erum Habib, Izmal Urooj, Hamna Danyal Barry, Muhammad Awais, Muskan Kumari, Fatima Hajj · 2026
Read AI-programmable therapeutics via metagenomic foundation models for rare phage-mediated autoimmune modulations: early translational risks and benefits by Erum Habib, Izmal Urooj, Hamna Danyal Barry, Muhammad Awais, Muskan Kumari, Fatima Hajj (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13236125.txt.
Description
Erum Habib and five co-authors wrote a 2026 letter on AI-designed treatments that edit gut microbes. Autoimmune diseases, from lupus to Crohn's disease, arise when the immune system attacks the body. Rare dynamics between gut bacteria and the viruses that infect them may spark some flares. Current drugs blunt the whole immune system and often give only partial relief.
New foundation models trained on vast gene data from microbes can design enzymes to rebalance the gut. Early reports claim promise where standard care fails. The letter weighs early gains against real risks of moving such tools toward patients. It stresses that design studies so far show feasibility, not proof in any one disease.
Catalog record
| CREATOR | Erum Habib, Izmal Urooj, Hamna Danyal Barry, Muhammad Awais, Muskan Kumari, Fatima Hajj |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |